Logo image of VENU

VENU HOLDING CORP (VENU) Stock Fundamental Analysis

NYSEARCA:VENU - NYSE Arca - US92333E1047 - Common Stock - Currency: USD

8.31  +0.38 (+4.79%)

Fundamental Rating

2

Taking everything into account, VENU scores 2 out of 10 in our fundamental rating. VENU was compared to 136 industry peers in the Hotels, Restaurants & Leisure industry. VENU has a bad profitability rating. Also its financial health evaluation is rather negative. VENU is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

VENU had negative earnings in the past year.
In the past year VENU had a positive cash flow from operations.
VENU Yearly Net Income VS EBIT VS OCF VS FCFVENU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

VENU has a worse Return On Assets (-17.00%) than 90.44% of its industry peers.
The Return On Equity of VENU (-31.70%) is worse than 60.29% of its industry peers.
Industry RankSector Rank
ROA -17%
ROE -31.7%
ROIC N/A
ROA(3y)-14.25%
ROA(5y)N/A
ROE(3y)-36.43%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VENU Yearly ROA, ROE, ROICVENU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -10 -20 -30 -40

1.3 Margins

VENU has a Gross Margin (47.59%) which is comparable to the rest of the industry.
The Profit Margin and Operating Margin are not available for VENU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47.59%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VENU Yearly Profit, Operating, Gross MarginsVENU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -50 -100 -150

More info and screens

3

2. Health

2.1 Basic Checks

VENU does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for VENU has been increased compared to 1 year ago.
The debt/assets ratio for VENU is higher compared to a year ago.
VENU Yearly Shares OutstandingVENU Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M
VENU Yearly Total Debt VS Total AssetsVENU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M

2.2 Solvency

VENU has an Altman-Z score of 1.58. This is a bad value and indicates that VENU is not financially healthy and even has some risk of bankruptcy.
VENU has a Altman-Z score (1.58) which is in line with its industry peers.
VENU has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.15, VENU belongs to the top of the industry, outperforming 83.09% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z 1.58
ROIC/WACCN/A
WACC8.56%
VENU Yearly LT Debt VS Equity VS FCFVENU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M -50M

2.3 Liquidity

A Current Ratio of 1.59 indicates that VENU should not have too much problems paying its short term obligations.
VENU has a Current ratio of 1.59. This is in the better half of the industry: VENU outperforms 76.47% of its industry peers.
VENU has a Quick Ratio of 1.58. This is a normal value and indicates that VENU is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.58, VENU is doing good in the industry, outperforming 77.94% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.59
Quick Ratio 1.58
VENU Yearly Current Assets VS Current LiabilitesVENU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 10M 20M 30M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for VENU have decreased strongly by -186.29% in the last year.
The Revenue has grown by 41.57% in the past year. This is a very strong growth!
EPS 1Y (TTM)-186.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.62%
Revenue 1Y (TTM)41.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-66.1%

3.2 Future

The Earnings Per Share is expected to grow by 114.33% on average over the next years. This is a very strong growth
Based on estimates for the next years, VENU will show a very strong growth in Revenue. The Revenue will grow by 225.43% on average per year.
EPS Next Y170.31%
EPS Next 2Y114.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year102.82%
Revenue Next 2Y225.43%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

VENU Yearly Revenue VS EstimatesVENU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 50M 100M 150M
VENU Yearly EPS VS EstimatesVENU Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0 0.5 -0.5 1 1.5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

VENU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 18.10, which indicates a rather expensive current valuation of VENU.
65.44% of the companies in the same industry are more expensive than VENU, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 20.86. VENU is around the same levels.
Industry RankSector Rank
PE N/A
Fwd PE 18.1
VENU Price Earnings VS Forward Price EarningsVENU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VENU Per share dataVENU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as VENU's earnings are expected to grow with 114.33% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y114.33%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

VENU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VENU HOLDING CORP

NYSEARCA:VENU (5/2/2025, 8:27:34 PM)

8.31

+0.38 (+4.79%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)03-31 2025-03-31/amc
Earnings (Next)N/A N/A
Inst Owners1.23%
Inst Owner Change10.73%
Ins Owners55.93%
Ins Owner Change0%
Market Cap311.63M
Analysts82.5
Price Target14.03 (68.83%)
Short Float %0.08%
Short Ratio0.97
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.33%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-28.3%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 18.1
P/S 17.47
P/FCF N/A
P/OCF 82.93
P/B 3.26
P/tB 3.26
EV/EBITDA N/A
EPS(TTM)-0.8
EYN/A
EPS(NY)0.46
Fwd EY5.52%
FCF(TTM)-1.83
FCFYN/A
OCF(TTM)0.1
OCFY1.21%
SpS0.48
BVpS2.55
TBVpS2.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17%
ROE -31.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 47.59%
FCFM N/A
ROA(3y)-14.25%
ROA(5y)N/A
ROE(3y)-36.43%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1982.49%
Cap/Sales 406.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.59
Quick Ratio 1.58
Altman-Z 1.58
F-Score4
WACC8.56%
ROIC/WACCN/A
Cap/Depr(3y)1444.24%
Cap/Depr(5y)N/A
Cap/Sales(3y)249.2%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-186.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.62%
EPS Next Y170.31%
EPS Next 2Y114.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)41.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-66.1%
Revenue Next Year102.82%
Revenue Next 2Y225.43%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-145.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-90.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y177.06%
OCF growth 3YN/A
OCF growth 5YN/A